{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:28:19Z","timestamp":1784219299847,"version":"3.55.0"},"reference-count":124,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Postgraduate Medicine"],"published-print":{"date-parts":[[2016,1,2]]},"DOI":"10.1080\/00325481.2016.1120642","type":"journal-article","created":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T21:10:09Z","timestamp":1447449009000},"page":"85-96","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":80,"title":["Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations"],"prefix":"10.1080","volume":"128","author":[{"given":"Maciej","family":"Gasior","sequence":"first","affiliation":[{"name":"TEVA Pharmaceuticals, Frazer, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Bond","sequence":"additional","affiliation":[{"name":"TEVA Pharmaceuticals, Frazer, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Malamut","sequence":"additional","affiliation":[{"name":"TEVA Pharmaceuticals, Frazer, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,12,18]]},"reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2008.10.008"},{"key":"e_1_3_1_3_1","unstructured":"United Nations Office on Drugs and Crime. World Drug Report 2015. [cited 2015 Oct 20]. Available from: http:\/\/www.unodc.org\/documents\/wdr2015\/World_Drug_Report_2015.pdf"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.05.053"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2007.00370.x"},{"key":"e_1_3_1_6_1","unstructured":"Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality. Behavioral health trends in the United States: results from the 2014 National Survey on Drug Use and Health. HHS Publication No. SMA 15-4927 NSDUH Series H-50. 2015 [cited 2015 Oct 20]. Available from: http:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-FRR1-2014\/NSDUH-FRR1-2014.htm"},{"key":"e_1_3_1_7_1","volume-title":"Treatment Episode Data Set (TEDS): 2002-2012. National Admissions to Substance Abuse Treatment Services. BHSIS Series S-71, HHS Publication No. (SMA) 14-4850","author":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality","year":"2014","unstructured":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. 2014. Treatment Episode Data Set (TEDS): 2002-2012. National Admissions to Substance Abuse Treatment Services. BHSIS Series S-71, HHS Publication No. (SMA) 14-4850. Rockville (MD): Substance Abuse and Mental Health Services Administration. [cited 2015 Oct 20]. Available from: http:\/\/www.samhsa.gov\/data\/sites\/default\/files\/TEDS2012N_Web.pdf"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.3.249"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1159\/000337028"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.36076\/ppj.2012\/15\/ES9"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12446"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2006.05.022"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.19.2087"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2011.01075.x"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1089\/pop.2013.0098"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2011.569623"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.3109\/15360288.2012.734905"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1991.tb01754.x"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.07.004"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2013.07.2684"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.11.027"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2005.11.035"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v23n04_01"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/J354v20n02_03"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2007.07050252"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1659"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.08.008"},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e318167a087"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2010.0022"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-8-29"},{"key":"e_1_3_1_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2011.609805"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12475"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00482-014-1466-7"},{"key":"e_1_3_1_34_1","doi-asserted-by":"publisher","DOI":"10.4103\/0976-0105.160751"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12279"},{"key":"e_1_3_1_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2009.00736.x"},{"key":"e_1_3_1_37_1","unstructured":"Villapiano A Butler SF Budman SH et al. Demonstration of the feasibility of real-time product-specific prescription opioid abuse surveillance: the NAVIPPRO system. Poster presented at: Annual Meeting of the College on Problems of Drug Dependence; 2006 Jun 20; Scottsdale AZ. Poster 173."},{"key":"e_1_3_1_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.02.012"},{"key":"e_1_3_1_39_1","doi-asserted-by":"publisher","DOI":"10.1053\/ajem.2002.29562"},{"key":"e_1_3_1_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881104042634"},{"key":"e_1_3_1_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1556-4029.2007.00597.x"},{"key":"e_1_3_1_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEJ.0b013e3283207fbd"},{"key":"e_1_3_1_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2006.00832.x"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.legalmed.2010.03.001"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/495938"},{"key":"e_1_3_1_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/PAF.0b013e3181651b66"},{"key":"e_1_3_1_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2011.05.017"},{"key":"e_1_3_1_48_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2002.tb04951.x"},{"key":"e_1_3_1_49_1","doi-asserted-by":"publisher","DOI":"10.1520\/JFS04143"},{"key":"e_1_3_1_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.paf.0000127398.67081.11"},{"key":"e_1_3_1_51_1","first-page":"75","article-title":"Inhalation abuse of fentanyl patch","volume":"32","author":"Marquardt KA","year":"1994","unstructured":"Marquardt KA, Tharratt RS. Inhalation abuse of fentanyl patch. Clin Toxicol. 1994;32:75\u201378.","journal-title":"Clin Toxicol"},{"key":"e_1_3_1_52_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-1462"},{"key":"e_1_3_1_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2005.06.450"},{"key":"e_1_3_1_54_1","first-page":"30","article-title":"The fentanyl tea bag","volume":"46","author":"Barrueto F","year":"2004","unstructured":"Barrueto F Jr, Howland MA, Hoffman RS, et al. The fentanyl tea bag. Vet Hum Toxicol. 2004;46:30\u201331.","journal-title":"Vet Hum Toxicol"},{"key":"e_1_3_1_55_1","article-title":"[Fentanyl tea]","volume":"17","author":"Darling SS","year":"2014","unstructured":"Darling SS, M\u00e6rkedahl R. [Fentanyl tea]. Ugeskr Laeger. 2014;17:176(8A). Danish.","journal-title":"Ugeskr Laeger"},{"key":"e_1_3_1_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12412"},{"key":"e_1_3_1_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(02)00312-5"},{"key":"e_1_3_1_58_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550490490440780"},{"key":"e_1_3_1_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.09.012"},{"key":"e_1_3_1_60_1","doi-asserted-by":"publisher","DOI":"10.1080\/09595230701829553"},{"key":"e_1_3_1_61_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874473711104010028"},{"key":"e_1_3_1_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2013.06.017"},{"key":"e_1_3_1_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.302.6782.969-b"},{"key":"e_1_3_1_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2008.07.018"},{"key":"e_1_3_1_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2010.10.004"},{"key":"e_1_3_1_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.12.005"},{"key":"e_1_3_1_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2014.02.003"},{"key":"e_1_3_1_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e31819c2c2f"},{"key":"e_1_3_1_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2010.06.018"},{"key":"e_1_3_1_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.08.026"},{"key":"e_1_3_1_71_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2011.596982"},{"key":"e_1_3_1_72_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-7-24"},{"key":"e_1_3_1_73_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2005.11.6.469"},{"key":"e_1_3_1_74_1","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2010.516346"},{"key":"e_1_3_1_75_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.03803.x"},{"key":"e_1_3_1_76_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2013.301812"},{"key":"e_1_3_1_77_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2014.302142"},{"key":"e_1_3_1_78_1","first-page":"35","article-title":"Associations between prescription opioid injection and hepatitis C virus among young injection drug users","volume":"22","author":"Lankenau SE","year":"2015","unstructured":"Lankenau SE, Kecojevic A, Silva K. Associations between prescription opioid injection and hepatitis C virus among young injection drug users. Drugs (Abingdon Engl). 2015;22:35\u201342.","journal-title":"Drugs (Abingdon Engl)"},{"key":"e_1_3_1_79_1","first-page":"443","article-title":"Community outbreak of HIV infection linked to injection drug use of oxymorphone\u2013Indiana, 2015","volume":"64","author":"Conrad C","year":"2015","unstructured":"Conrad C, Bradley HM, Broz D, et al. Community outbreak of HIV infection linked to injection drug use of oxymorphone\u2013Indiana, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:443\u2013444.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_1_80_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113991"},{"key":"e_1_3_1_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13503"},{"key":"e_1_3_1_82_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-010-9230-y"},{"key":"e_1_3_1_83_1","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.14.12582"},{"key":"e_1_3_1_84_1","first-page":"34","article-title":"Infective endocarditis secondary to intravenous Subutex abuse","volume":"50","author":"Chong E","year":"2009","unstructured":"Chong E, Poh KK, Shen L, et al. Infective endocarditis secondary to intravenous Subutex abuse. Singapore Med J. 2009;50:34\u201342.","journal-title":"Singapore Med J"},{"key":"e_1_3_1_85_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990902939719"},{"key":"e_1_3_1_86_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129360"},{"key":"e_1_3_1_87_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.23542"},{"key":"e_1_3_1_88_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.21001"},{"key":"e_1_3_1_89_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.21355"},{"key":"e_1_3_1_90_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.272"},{"key":"e_1_3_1_91_1","unstructured":"Centers for Disease Control and Prevention. CDC Vitalsigns\u2122: opioid painkiller prescribing. 2014 Jul [cited 2015 Oct 20]. Available from: http:\/\/www.cdc.gov\/vitalsigns\/pdf\/2014-07-vitalsigns.pdf"},{"key":"e_1_3_1_92_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2014.987397"},{"key":"e_1_3_1_93_1","unstructured":"Centers for Disease Control and Prevention. Policy impact: prescription painkiller overdoses. 2011 Nov [cited 2015 Oct 20]. Available from: http:\/\/www.cdc.gov\/HomeandRecreationalSafety\/pdf\/PolicyImpact-PrescriptionPainkillerOD.pdf"},{"key":"e_1_3_1_94_1","first-page":"295","article-title":"Prescription opioid abuse: challenges and opportunities for payers","volume":"19","author":"Katz NP","year":"2013","unstructured":"Katz NP, Birnbaum H, Brennan MJ, et al. Prescription opioid abuse: challenges and opportunities for payers. Am J Manag Care. 2013;19:295\u2013302.","journal-title":"Am J Manag Care"},{"key":"e_1_3_1_95_1","doi-asserted-by":"publisher","DOI":"10.2165\/11584260-000000000-00000"},{"key":"e_1_3_1_96_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2013.751095"},{"key":"e_1_3_1_97_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-012-0270-y"},{"key":"e_1_3_1_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.02.006"},{"key":"e_1_3_1_99_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2015.979786"},{"key":"e_1_3_1_100_1","first-page":"305","article-title":"Abuse-deterrent formulations: part 2: commercial products and proprietary technologies","volume":"16","author":"Mastropietro DJ","year":"2015","unstructured":"Mastropietro DJ, Omidian H. Abuse-deterrent formulations: part 2: commercial products and proprietary technologies. Expert Opin Drug Metab Toxicol. 2015;16:305\u2013323.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"e_1_3_1_101_1","unstructured":"Food and Drug Administration. Abuse-deterrent opioids: evaluation and labeling guidance for industry. 2015 Apr [cited 2015 Oct 20]. Available from: http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm334743.pdf"},{"key":"e_1_3_1_102_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113493364"},{"key":"e_1_3_1_103_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.235"},{"key":"e_1_3_1_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-014-0192-3"},{"key":"e_1_3_1_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2009.07.017"},{"key":"e_1_3_1_106_1","doi-asserted-by":"publisher","DOI":"10.2165\/11530800-000000000-00000"},{"key":"e_1_3_1_107_1","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2013.0155"},{"key":"e_1_3_1_108_1","doi-asserted-by":"publisher","DOI":"10.2165\/11593390-000000000-00000"},{"key":"e_1_3_1_109_1","first-page":"71","article-title":"Extended-release hydrocodone (Hysingla ER) for pain","volume":"57","year":"2015","unstructured":"Extended-release hydrocodone (Hysingla ER) for pain. Med Lett Drugs Ther. 2015;57:71\u201372.","journal-title":"Med Lett Drugs Ther"},{"key":"e_1_3_1_110_1","unstructured":"Inspiron Delivery Technologies LLC. Inspirion Delivery Technologies receives FDA approval for MorphaBond\u2122 (morphine sulfate) extended-release tablets CII an opioid analgesic formulated with abuse-deterrent properties. 2015 Oct 5 [cited 2015 Oct 20]. Available from: http:\/\/www.prnewswire.com\/news-releases\/inspirion-delivery-technologies-receives-fda-approval-for-morphabond-morphine-sulfate-extended-release-tablets-cii-an-opioid-analgesic-formulated-with-abuse-deterrent-properties-300153910.html?$G1Ref"},{"key":"e_1_3_1_111_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1204141"},{"key":"e_1_3_1_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2012.08.008"},{"key":"e_1_3_1_113_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3522"},{"key":"e_1_3_1_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2013.04.011"},{"key":"e_1_3_1_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.02.018"},{"key":"e_1_3_1_116_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3658"},{"key":"e_1_3_1_117_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.3043"},{"key":"e_1_3_1_118_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1406143"},{"key":"e_1_3_1_119_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.0914"},{"key":"e_1_3_1_120_1","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2015.0269"},{"key":"e_1_3_1_121_1","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12489"},{"key":"e_1_3_1_122_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2014.897628"},{"key":"e_1_3_1_123_1","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12295"},{"key":"e_1_3_1_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2015.05.023"},{"key":"e_1_3_1_125_1","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.3397"}],"container-title":["Postgraduate Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00325481.2016.1120642","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:59:46Z","timestamp":1770418786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00325481.2016.1120642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,18]]},"references-count":124,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1,2]]}},"alternative-id":["10.1080\/00325481.2016.1120642"],"URL":"https:\/\/doi.org\/10.1080\/00325481.2016.1120642","relation":{},"ISSN":["0032-5481","1941-9260"],"issn-type":[{"value":"0032-5481","type":"print"},{"value":"1941-9260","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgm20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgm20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-10-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-11-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-12-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}